AtaiBeckley (ATAI) to Initiate Phase 3 Depression Study Following Positive FDA Meeting
AtaiBeckley Inc. (NASDAQ:ATAI) is one of the best low cost stocks to buy under $5. On March 3, AtaiBeckley announced a successful End-of-Phase 2 meeting with the FDA regarding BPL-003, a proprietary intranasal formulation of mebufotenin benzoate for treatment-resistant depression/TRD. The FDA indicated support for the proposed Phase 3 program, providing constructive feedback on the [...]